Sign in →

Test ID LBOR0216 Chromosome Analysis, Congenital Disorders

Important Note

Note:  Send completed Sanford Medical Genetics Requisition along with specimen.  

For non-Medicare patients, a separate completed and signed Commercial Insurance Patient Waiver of Liability is required to accompany the specimen.

For patients with Blue Cross Blue Shield of North Dakota Coverage, a separate completed and signed Advance Member Notice is required to accompany the specimen.  

AKA

Ambiguous genitalia, chromosome analysis, Congenital karyotype analysis, Constitutional Study, Familial chromosome abnormality, Karyotype, Blood Stimulated, Klinefelter Syndrome, Trisomy 13 (Patau Syndrome), Trisomy 18 (Edward Syndrome), Trisomy 21 (Down Syndrome), Turner Syndrome, multiple miscarriages

Specimen Type/Requirements

Dark Green top (Sodium Heparin w/out gel) - Whole Blood

 

Invert several times to mix blood.  Send whole blood specimen in original tube.

Do not aliquot.

Specimen Volume

 Preferred Volume     4 mL             
 Minimum Volume     2 mL
 Infant Minimum Volume     1 mL   

 

 

Stability/Transport

 Room Temperature     48 - 72 hours     Preferred for transport   
  Refrigerated  48 - 72 hours     
 Frozen     Not Acceptable     

Note: Samples received after 24 hours may result in compromised specimen integrity.

All specimens will be evaluated at the Sanford Medical Genetics Laboratory for test suitability. 

Performed Test Frequency

Monday - Friday

Report Available

10 days

Additional Information

Method:
Whole blood is cultured with an additive to stimulate cell division. The cells are incubated for 48 hours at 37° Celsius. Cell cultures are synchronized with excess thymidine, arrested in metaphase with Colcemid, harvested, and fixed with methanol and acetic acid. Giemsa stain and trypsin are used to generate a characteristic banding pattern (G-banding) which permits unambiguous identification of individual chromosomes. (Arsham et al., The AGT Cytogenetics Laboratory Manual, Fourth Edition) 
Twenty metaphases with an average band-level resolution of 400-700 are routinely examined. An additional 30 metaphases are analyzed in cases of suspected mosaicism. Two or more digital karyograms are prepared and stored using a computer-based imaging system. An abbreviated study of 5 metaphases may be performed for testing ordered to confirm a known familial chromosome abnormality or as an add-on to a normal CMA result. Chromosome abnormalities are confirmed in at least 2 different cultures. A minimum of 3 metaphases with the same chromosome loss, and a minimum of 2 metaphases with the same chromosome gain or structural abnormality are required to authenticate findings. (ACMG, Technical Standards for Clinical Genetics Laboratories (2021 Revision)) 

 

Limitations: 
Chromosomes at the 400-700 band-level of resolution generally have a detection limit of 5-10 megabases in regions where the banding pattern is distinctive. The detection limit may be adversely affected in regions lacking contrasting bands. Smaller genomic abnormalities may not be detected via G-banded chromosome studies (cryptic abnormalities). Some chromosomal anomalies hinder cell growth and may be selected against during routine cell culture processes resulting in underrepresentation or exclusion during final analysis. This test is not appropriate for detecting acquired chromosome abnormalities.

Methodology

Karyotyping

Performing Lab

Sanford Medical Genetics Laboratory - Sioux Falls

CPT

88230 AND 88291

and one of the following: 88261 or 88262 or 88263